Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AtriCure Inc ATRC

Healthcare Medical Devices
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze... see more

Recent & Breaking News (NDAQ:ATRC)

Mid-Morning Market Update: Markets Mostly Higher; Mastercard Beats Q3 Views

Benzinga.com  October 28, 2016

AtriCure Reports Third Quarter 2016 Financial Results

Business Wire October 27, 2016

AtriCure Announces Upcoming Investor Conference Schedule

Business Wire October 24, 2016

AtriCure to Announce Third Quarter 2016 Financial Results

Business Wire October 4, 2016

AtriCure to Present at the Morgan Stanley Global Healthcare Conference

Business Wire August 18, 2016

AtriCure Reports Second Quarter 2016 Financial Results

Business Wire August 4, 2016

BMO Capital Highlights This Week's MedTech Earnings

Benzinga.com  August 1, 2016

AtriCure to Present at the Canaccord Genuity Growth Conference

Business Wire July 22, 2016

AtriCure to Announce Second Quarter 2016 Financial Results

Business Wire July 11, 2016

AtriCure Receives CE Mark for the AtriClip® PRO2 Device

Business Wire June 29, 2016

AtriCure Announces the First Patient Enrolled in the FROST Cryoanalgesia Study

Business Wire June 21, 2016

AtriCure to Present at the UBS Global Healthcare Conference

Business Wire May 2, 2016

AtriCure Reports First Quarter 2016 Financial Results

Business Wire April 28, 2016

AtriCure Announces $25 Million Term Loan with Silicon Valley Bank

Business Wire April 28, 2016

AtriCure Receives FDA Clearance for New AtriClip® Device

Business Wire April 26, 2016

AtriCure Announces 510(k) Clearance for the cryoFORM(TM) Cryoablation Probe

Business Wire April 12, 2016

AtriCure to Announce First Quarter 2016 Financial Results

Business Wire April 5, 2016

AtriCure Reports Fourth Quarter and Full Year 2015 Financial Results

Business Wire February 23, 2016

AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib

Press Releases February 17, 2016

AtriCure to Announce Fourth Quarter and Full Year 2015 Financial Results

Business Wire February 1, 2016